Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06062615 · ClinicalTrials.gov registry record · NA
Robotic Assisted TKA
A NA study, sponsored by Rothman Institute Orthopaedics.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT06062615: Completed NA study, sponsored by Rothman Institute Orthopaedics.
NCT06062615 is a NA study that has completed, run by Rothman Institute Orthopaedics. The registered enrollment target is 60 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06062615, a NA study, has completed, sponsored by Rothman Institute Orthopaedics.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
As an intraoperative tool, a modern robotic total knee arthroplasty (TKA) system should be able to identify a patient's native femoral and tibial anatomy, as well as, assess ligament tension and gap balance. The surgeon in real time is then able to develop and execute a patient specific plan in terms of component size, alignment and rotation. In our institution we have begun to use, the OMNIBotics Knee system (Corin), which utilizes an active motorized knee spacer, BalanceBot, to objectively measure ligament tension and gap balance after the tibia has been cut and its alignment confirmed. This information is then processed through the OMNIbotics computer algorithm to appropriately size, align, and rotate the femur component to balance the flexion and extension gaps. The purpose of this study is to perform a randomized pilot study looking for an effect on early functional outcomes comparing robotic assisted TKA (RATKA) versus conventional TKA technique.
Primary Outcome
This will be measured by the timed-up-and-go test.
Interventions
- PROCEDURE Total knee replacement using Omnibot Knee System
- PROCEDURE Conventional Total knee replacement
- DEVICE Omnibot Robotic Knee System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2022-07-01 |
| Est. Completion | 2023-12-31 |
| Phase | NA |
What the finished NCT06062615 record still lists
NCT06062615 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 3 interventions - of which Total knee replacement using Omnibot Knee System is the first listed.
NCT06062615 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06062615 about?
NCT06062615 is a clinical study titled "Robotic Assisted TKA". As an intraoperative tool, a modern robotic total knee arthroplasty (TKA) system should be able to identify a patient's native femoral and tibial anatomy, as well as, assess ligament tension and gap balance. The surgeon in real time is then able to develop and execute a patient specific plan in term...
What is the current status of trial NCT06062615?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2022-07-01. Estimated completion is 2023-12-31.
What interventions are being tested in trial NCT06062615?
The interventions under investigation include: Total knee replacement using Omnibot Knee System (PROCEDURE), Conventional Total knee replacement (PROCEDURE), Omnibot Robotic Knee System (DEVICE).
Who is sponsoring clinical trial NCT06062615?
This trial is sponsored by Rothman Institute Orthopaedics, which has 23 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06062615's enrollment target sits among peer trials
60 1164th of 2000 higher than 745 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI